Executive Advisory at the Intersection of Science, Strategy, and Leadership
Founded and led by Dr. Aparna Ahuja, MD — Physician Executive
We provide trusted advisory at the moments that define organizations. Physician Executive–led, our firm integrates scientific insight, enterprise strategy, evidence generation, operational excellence, and organizational leadership.
Dr Aparna Ahuja has led medical and clinical strategy at Becton Dickinson and Abbott—two of the world’s leading global healthcare organizations as well as T2 Biosystems, an innovative, high-growth diagnostics company. This combination brings:
Consequential. Complex. Irreversible. When you need independent judgment to navigate uncertainty, frame decisions, and align scientific rigor with enterprise value.
Decisions that shape the trajectory of enterprises, portfolios, and teams. We bring clarity when the stakes are highest.
Complex, multi-variable situations demand more than frameworks—they demand judgment honed through decades of operational leadership.
Aligning scientific evidence, regulatory pathways, and commercial strategy into a coherent enterprise narrative that drives outcomes.
Eight advisory domains. Each grounded in operating experience, delivered at the executive level.
C-suite and board-level advisory on strategic direction, organizational design, and enterprise decision-making.
Optimizing portfolio prioritization, pipeline valuation, and investment allocation for maximum enterprise impact.
Bridging the gap between clinical evidence generation and commercial strategy for seamless go-to-market execution.
Structuring strategic alliances and partnership frameworks that accelerate growth.
Deep domain advisory across companion diagnostics, molecular testing, and precision health strategy.
Due diligence, market assessment, and strategic evaluation for investors and private equity in life sciences.
Driving efficiency, governance, and scalable operating models across medical affairs and commercial organizations. From strategy through implementation.
Workflow optimization. Accreditation support. Lean Six Sigma frameworks. Alignment of lab performance with outcomes.
Our firm brings specialized knowledge built through decades of hands-on leadership across global life sciences.
Three engagement models—each direct, scoped, and trust-based. No teams of juniors. No bloated scopes.
Ongoing advisory relationship with direct access. Retained engagements for C-suite and board-level leaders navigating complex decisions.
RetainedDefined deliverable, clear timeline. Ideal for due diligence, portfolio reviews, market assessments, product launch activities, clinical programs, and strategic planning cycles.
Project-BasedFocused, high-impact sessions for specific questions, regulatory & clinical compliance, investor diligence calls, or board preparation. Rapid-turnaround advisory.
On-Demand
Dr. Aparna Ahuja, MD, is the founder and principal of AJA Life Sciences Advisory. A physician-executive and senior leader in global life sciences, she brings more than three decades of experience across healthcare innovation systems, medical affairs, clinical development, in-vitro diagnostics, precision medicine, MedTech, clinical diagnostics & research laboratories, commercial strategy, regulatory and clinical compliance, and with executive roles at Becton Dickinson, Abbott, T2 Biosystems, Agilus Diagnostics (formerly SRL), and Dr Lal PathLabs.
Trusted advisor to executive teams and boards on clinical strategy, evidence generation, regulatory pathways, and enterprise decision-making. Recognized for building and leading global organizations that translate science into strategy, and strategy into adoption, across complex healthcare ecosystems.
Dr. Ahuja’s work sits at the intersection of scientific rigor, enterprise strategy, and healthcare transformation—helping organizations navigate high-stakes decisions with clarity, independence, and depth. She founded AJA Life Sciences Advisory to bring that perspective directly to CEOs, boards, investors, and innovation leaders.
AJA Life Sciences Advisory works with a limited number of clients to ensure depth, focus, and confidentiality. If you're facing a consequential decision, we'd welcome the conversation.